BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 21051718)

  • 1. Contrast sensitivity mediated by inferred magno- and parvocellular pathways in type 2 diabetics with and without nonproliferative retinopathy.
    Gualtieri M; Bandeira M; Hamer RD; Damico FM; Moura AL; Ventura DF
    Invest Ophthalmol Vis Sci; 2011 Feb; 52(2):1151-5. PubMed ID: 21051718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced Contrast Sensitivity is Associated With Elevated Equivalent Intrinsic Noise in Type 2 Diabetics Who Have Mild or No Retinopathy.
    McAnany JJ; Park JC
    Invest Ophthalmol Vis Sci; 2018 May; 59(6):2652-2658. PubMed ID: 29847671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spatial summation properties for magnocellular and parvocellular pathways in glaucoma.
    Battista J; Badcock DR; McKendrick AM
    Invest Ophthalmol Vis Sci; 2009 Mar; 50(3):1221-6. PubMed ID: 18936145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Reduction of retinal light sensitivity in diabetic patients].
    Pahor D
    Klin Monbl Augenheilkd; 2003 Dec; 220(12):868-72. PubMed ID: 14704945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Independent patterns of damage within magno-, parvo- and koniocellular pathways in Parkinson's disease.
    Silva MF; Faria P; Regateiro FS; Forjaz V; Januário C; Freire A; Castelo-Branco M
    Brain; 2005 Oct; 128(Pt 10):2260-71. PubMed ID: 16000338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anisometropic amblyopia: spatial contrast sensitivity deficits in inferred magnocellular and parvocellular vision.
    Zele AJ; Pokorny J; Lee DY; Ireland D
    Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3622-31. PubMed ID: 17652732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrast sensitivity changes due to glaucoma and normal aging: low-spatial-frequency losses in both magnocellular and parvocellular pathways.
    McKendrick AM; Sampson GP; Walland MJ; Badcock DR
    Invest Ophthalmol Vis Sci; 2007 May; 48(5):2115-22. PubMed ID: 17460269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inner retinal visual dysfunction is a sensitive marker of non-proliferative diabetic retinopathy.
    Jackson GR; Scott IU; Quillen DA; Walter LE; Gardner TW
    Br J Ophthalmol; 2012 May; 96(5):699-703. PubMed ID: 22174096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early detection of changes in visual function in diabetes mellitus.
    Ismail GM; Whitaker D
    Ophthalmic Physiol Opt; 1998 Jan; 18(1):3-12. PubMed ID: 9666905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Characters of contrast sensitivity in diabetic patients without diabetic retinopathy].
    Sun TS; Zhang MN
    Zhonghua Yan Ke Za Zhi; 2012 Jan; 48(1):41-6. PubMed ID: 22490915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential changes of magnocellular and parvocellular visual function in early- and late-onset strabismic amblyopia.
    Davis AR; Sloper JJ; Neveu MM; Hogg CR; Morgan MJ; Holder GE
    Invest Ophthalmol Vis Sci; 2006 Nov; 47(11):4836-41. PubMed ID: 17065495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychophysical analysis of contrast processing segregated into magnocellular and parvocellular systems in asymptomatic carriers of 11778 Leber's hereditary optic neuropathy.
    Gualtieri M; Bandeira M; Hamer RD; Costa MF; Oliveira AG; Moura AL; Sadun F; De Negri AM; Berezovsky A; Salomão SR; Carelli V; Sadun AA; Ventura DF
    Vis Neurosci; 2008; 25(3):469-74. PubMed ID: 18598420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low spatial frequency contrast sensitivity deficits in migraine are not visual pathway selective.
    McKendrick AM; Sampson GP
    Cephalalgia; 2009 May; 29(5):539-49. PubMed ID: 19250285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional loss in the magnocellular and parvocellular pathways in patients with optic neuritis.
    Cao D; Zele AJ; Pokorny J; Lee DY; Messner LV; Diehl C; Ksiazek S
    Invest Ophthalmol Vis Sci; 2011 Nov; 52(12):8900-7. PubMed ID: 22016061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Foveal contrast processing of increment and decrement targets is equivalently reduced in glaucoma.
    Sampson GP; Badcock DR; Walland MJ; McKendrick AM
    Br J Ophthalmol; 2008 Sep; 92(9):1287-92. PubMed ID: 18614574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measuring retinal sensitivity with the microperimeter in patients with diabetes.
    Nittala MG; Gella L; Raman R; Sharma T
    Retina; 2012 Jul; 32(7):1302-9. PubMed ID: 22450513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of transient attention on inferred parvocellular and magnocellular processing.
    Yeshurun Y; Sabo G
    Vision Res; 2012 Dec; 74():21-9. PubMed ID: 22727937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of contrast gain signature in inferred magnocellular and parvocellular pathways in patients with glaucoma.
    Sun H; Swanson WH; Arvidson B; Dul MW
    Vision Res; 2008 Nov; 48(26):2633-41. PubMed ID: 18501947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vernier threshold in patients with schizophrenia and in their unaffected siblings.
    Kéri S; Kelemen O; Benedek G; Janka Z
    Neuropsychology; 2004 Jul; 18(3):537-42. PubMed ID: 15291731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local retinal sensitivity in relation to specific retinopathy lesions in diabetic macular oedema.
    Soliman W; Hasler P; Sander B; Larsen M
    Acta Ophthalmol; 2012 May; 90(3):248-53. PubMed ID: 20809906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.